臨床薬理
Online ISSN : 1882-8272
Print ISSN : 0388-1601
ISSN-L : 0388-1601
シンポジウム16 国際共同治験における用量差とエビデンス
2. 国際共同治験における用量差とエビデンス
中村 哲也
著者情報
ジャーナル フリー

2011 年 42 巻 2 号 p. 57-58

詳細
抄録
Recent breakthroughs in science and technology have the potential to transform our ability to prevent, diagnose and treat disease. Global clinical trials are expanding. A number of difficulties emerged in conducting global clinical trials in Japan. Ethnic factors in multinational clinical trials have been apparent to determine drug dosing. Regulatory science is the science of developing new tools, standards, and approaches to assess the safety, efficacy, quality, and performance. It is important to promote regulatory science for establishment of evidence-based medicine.
著者関連情報
© 2011 日本臨床薬理学会
前の記事 次の記事
feedback
Top